Literature DB >> 7814283

Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae.

I R Friedland1, M Paris, S Shelton, G H McCracken.   

Abstract

Time-kill studies were conducted to evaluate antibiotic combinations against four strains of Streptococcus pneumoniae for which the MICs of penicillin were 0.03, 0.25, 1 and 4 mg/L, respectively. After 8 h of antibiotic exposure the combination of ceftriaxone and vancomycin showed enhanced activity against all four strains. Penicillin plus vancomycin and ceftriaxone plus gentamicin showed enhanced activity against the three penicillin-resistant strains. Combinations of vancomycin and rifampicin were indifferent. These results are similar to those found previously in the rabbit meningitis model suggesting that time-kill studies over 8 h may be useful in predicting in-vivo antibiotic interactions in resistant pneumococcal infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814283     DOI: 10.1093/jac/34.2.231

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  18 in total

1.  Gentamicin increases the efficacy of vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.

Authors:  Philippe Cottagnoud; Cynthia M Gerber; Marianne Cottagnoud; Martin G Täuber
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Therapy of suspected bacterial meningitis in Canadian children six weeks of age and older.

Authors: 
Journal:  Paediatr Child Health       Date:  2001-03       Impact factor: 2.253

3.  Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.

Authors:  I R Friedland; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.

Authors:  K Tateda; K Takashima; H Miyazaki; T Matsumoto; T Hatori; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

5.  Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.

Authors:  M E Falagas; L McDermott; D R Snydman
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

6.  Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.

Authors:  C Doit; J Barre; R Cohen; S Bonacorsi; A Bourrillon; E H Bingen
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

7.  Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.

Authors:  C Darras-Joly; J P Bédos; C Sauve; P Moine; E Vallée; C Carbon; E Azoulay-Dupuis
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

8.  Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.

Authors:  I Lutsar; A Ahmed; I R Friedland; M Trujillo; L Wubbel; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 9.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

10.  In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin.

Authors:  K P Giron; M E Gross; D M Musher; T W Williams; R A Tharappel
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.